Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination With Everolimus or Pembrolizumab Versus Sunitinib Alone in First-Line Treatment of Subjects With Advanced Renal Cell Carcinoma (CLEAR) |
|---|---|
| Disease/Condition | Kidney Diseases (incl Chronic Kidney Disease),Kidney Cancer,Oncology (Medical/Hematologic),Urologic Oncology (Med Onc),Urologic Diseases,Carcinoma,Urogenital Neoplasms |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Benjamin Gartrell, MD |
| Contact Name | Gina Aracena |
| Contact Email | gihernan@montefiore.org |
| Protocol Number | 17-06-208Q-01 |
| Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Medical and Hematologic Oncology - Kidney |
| Adult, Pediatric, Both | Adult |
